Preferred
(EDT)
Other
Targeting Novel Mechanisms
LKB1/STK11 Axis in Precision Immunotherapy
11:15 AM - 11:40 AM EDT
Monday, June 21, 2021Speaker
John Heymach, MD, PhD
University of Texas MD Anderson Cancer Center
Targeting Novel Mechanisms
Structural Basis for the Action of Clinical MEK Inhibitors at KSR-Bound MEK
11:40 AM - 12:05 PM EDT
Monday, June 21, 2021Speaker
Arvin Dar, PhD
Icahn School of Medicine at Mount Sinai
Targeting Novel Mechanisms
Non-Cell Autonomous Tumor Control via Senescence
12:05 PM - 12:30 PM EDT
Monday, June 21, 2021Speaker
Scott Lowe, PhD
Memorial Sloan Kettering Cancer Center
Targeting Novel Mechanisms
Short Talk: Eganelisib (IPI-549) Activity as a Macrophage Reprogramming Therapeutic Candidate in 1L Metastatic TNBC, 2L Metastatic Urothelial Cancer and Other Solid Tumors
12:30 PM - 12:45 PM EDT
Monday, June 21, 2021Speaker
Brian Schwartz, MD
Infinity Pharmaceuticals, Inc.
SciTalk
Targeting Novel Mechanisms
Short Talk: SCD1-Regulated Ferroptosis as a Novel Therapeutic Strategy in Non-Small Cell Lung Cancer
12:45 PM - 1:00 PM EDT
Monday, June 21, 2021Speaker
Triparna Sen, PhD
Memorial Sloan Kettering Cancer Center
Targeting Novel Mechanisms
